{
  "trial_id": "NCT00322621",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes, type of diabetes (Type I or Type II), baseline Brief Pain Inventory (BPI) 24-hour average pain item score, baseline HbA1c levels, baseline blood pressure, baseline body mass index (BMI), baseline use of pain medications, baseline use of antidepressants, baseline liver function tests, baseline kidney function tests, baseline cardiovascular health status, baseline peripheral vascular disease status, baseline psychiatric health status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Duration of Diabetes",
          "duration of diabetes"
        ],
        [
          "Type of Diabetes Mellitus",
          "type of diabetes (Type I or Type II)"
        ],
        [
          "Brief Pain Inventory 24-Hour Average Pain Severity",
          "baseline Brief Pain Inventory (BPI) 24-hour average pain item score"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Duration of Neuropathic Pain",
        "Race/Ethnicity",
        "Height at Visit 1 (Week -1)",
        "Weight at Visit 2 (Week 0)"
      ],
      "remaining_candidate_features": [
        "Age",
        "baseline HbA1c levels",
        "baseline blood pressure",
        "baseline body mass index (BMI)",
        "baseline use of pain medications",
        "baseline use of antidepressants",
        "baseline liver function tests",
        "baseline kidney function tests",
        "baseline cardiovascular health status",
        "baseline peripheral vascular disease status",
        "baseline psychiatric health status"
      ]
    },
    "processed-gen-response": "Age, gender, duration of diabetes, type of diabetes (Type I or Type II), baseline Brief Pain Inventory (BPI) 24-hour average pain item score, baseline HbA1c levels, baseline blood pressure, baseline body mass index (BMI), baseline use of pain medications, baseline use of antidepressants, baseline liver function tests, baseline kidney function tests, baseline cardiovascular health status, baseline peripheral vascular disease status, baseline psychiatric health status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline Pain Score, HbA1c, Body Mass Index, Blood Pressure, Concomitant Medications, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Duration of Diabetes",
          "Duration of Diabetes"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Brief Pain Inventory 24-Hour Average Pain Severity",
          "Baseline Pain Score"
        ]
      ],
      "remaining_reference_features": [
        "Height at Visit 1 (Week -1)",
        "Weight at Visit 2 (Week 0)",
        "Type of Diabetes Mellitus",
        "Duration of Neuropathic Pain"
      ],
      "remaining_candidate_features": [
        "Age",
        "HbA1c",
        "Body Mass Index",
        "Blood Pressure",
        "Concomitant Medications"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Baseline Pain Score, HbA1c, Body Mass Index, Blood Pressure, Concomitant Medications"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Type, Duration of Diabetic Peripheral Neuropathic Pain, Brief Pain Inventory (BPI) 24-hour Average Pain Item Score, Body Mass Index, Blood Pressure, HbA1c, Peripheral vascular disease, History of substance abuse or dependence.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Duration of Neuropathic Pain",
          "Duration of Diabetic Peripheral Neuropathic Pain"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Type of Diabetes Mellitus",
          "Diabetes Type"
        ],
        [
          "Brief Pain Inventory 24-Hour Average Pain Severity",
          "Brief Pain Inventory (BPI) 24-hour Average Pain Item Score"
        ]
      ],
      "remaining_reference_features": [
        "Duration of Diabetes",
        "Height at Visit 1 (Week -1)",
        "Weight at Visit 2 (Week 0)"
      ],
      "remaining_candidate_features": [
        "Age",
        "Body Mass Index",
        "Blood Pressure",
        "HbA1c",
        "Peripheral vascular disease",
        "History of substance abuse or dependence."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes Type, Duration of Diabetic Peripheral Neuropathic Pain, Brief Pain Inventory (BPI) 24-hour Average Pain Item Score, Body Mass Index, Blood Pressure, HbA1c, Peripheral vascular disease, History of substance abuse or dependence."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, duration of diabetic peripheral neuropathic pain, type of diabetes (I or II), HbA1c level, blood pressure, Brief Pain Inventory (BPI) 24-hour average pain item score at baseline, presence of comorbidities (cardiovascular, hepatic, kidney, respiratory, or blood disorders), history of substance abuse or dependence, use of concomitant medications (MAOI, fluoxetine, etc.).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ],
        [
          "Duration of Diabetes",
          "duration of diabetes"
        ],
        [
          "Duration of Neuropathic Pain",
          "duration of diabetic peripheral neuropathic pain"
        ],
        [
          "Type of Diabetes Mellitus",
          "type of diabetes (I or II)"
        ],
        [
          "Brief Pain Inventory 24-Hour Average Pain Severity",
          "Brief Pain Inventory (BPI) 24-hour average pain item score at baseline"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Height at Visit 1 (Week -1)",
        "Weight at Visit 2 (Week 0)"
      ],
      "remaining_candidate_features": [
        "Age",
        "body mass index (BMI)",
        "HbA1c level",
        "blood pressure",
        "presence of comorbidities (cardiovascular, hepatic, kidney, respiratory, or blood disorders)",
        "history of substance abuse or dependence",
        "use of concomitant medications (MAOI, fluoxetine, etc.)"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, duration of diabetic peripheral neuropathic pain, type of diabetes (I or II), HbA1c level, blood pressure, Brief Pain Inventory (BPI) 24-hour average pain item score at baseline, presence of comorbidities (cardiovascular, hepatic, kidney, respiratory, or blood disorders), history of substance abuse or dependence, use of concomitant medications (MAOI, fluoxetine, etc.)."
  }
}